CY2023 Q4
Loading, please wait
Company
|
Value
|
End Date
|
SEC Filing
|
|---|---|---|---|
| 10x Genomics, Inc. | $8,814,000.00 | 2023-12-31 | View |
| 1stdibs.com, Inc | $100,000.00 | 2023-12-31 | View |
| 23ANDME HOLDING CO | $15,000,000.00 | 2023-12-31 | View |
| 2seventy bio, Inc. | $3,918,000.00 | 2023-12-31 | View |
| 4D Molecular Therapeutics, Inc. | $972,000.00 | 2023-12-31 | View |
| 5&2 STUDIOS, INC. | $1,928,000.00 | 2023-12-31 | View |
| 8x8, INC. | $10,128,000.00 | 2023-12-31 | View |
| 908 DEVICES INC | $8,571,000.00 | 2023-12-31 | View |
| A10 NETWORKS, INC. | $58,677,000.00 | 2023-12-31 | View |
| AAR CORP | $9,800,000.00 | 2023-11-30 | View |
| AbCellera Biologics Inc. | $8,195,000.00 | 2023-12-31 | View |
| ABSCI CORP | $966,000.00 | 2023-12-31 | View |
| Acacia Research Corporation | $458,000.00 | 2023-12-31 | View |
| Accel Entertainment, Inc. | $4,955,000.00 | 2023-12-31 | View |
| ACCELERATE DIAGNOSTICS, INC. | $1,122,000.00 | 2023-12-31 | View |
| ACCOLADE, INC. | $120,000.00 | 2023-11-30 | View |
| ACCURAY INCORPORATED | $24,809,000.00 | 2023-12-31 | View |
| ACI WORLDWIDE, INC. | $24,780,000.00 | 2023-12-31 | View |
| Actelis Networks, Inc. | $71,000.00 | 2023-12-31 | View |
| ACTINIUM PHARMACEUTICALS, INC. | $35,000,000.00 | 2023-12-31 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations